New patent for Optinose Us drug XHANCE

Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. It is available from one supplier. There are twelve… The post New patent for Optinose Us drug XHANCE appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!